130 related articles for article (PubMed ID: 26137168)
1. Doxorubicin activates the Notch signaling pathway in osteosarcoma.
Mei H; Yu L; Ji P; Yang J; Fang S; Guo W; Liu Y; Chen X
Oncol Lett; 2015 Jun; 9(6):2905-2909. PubMed ID: 26137168
[TBL] [Abstract][Full Text] [Related]
2. Notch signaling is important for epithelial-mesenchymal transition induced by low concentrations of doxorubicin in osteosarcoma cell lines.
Yang J; Guo W; Wang L; Yu L; Mei H; Fang S; Chen A; Liu Y; Xia K; Liu G
Oncol Lett; 2017 Apr; 13(4):2260-2268. PubMed ID: 28454389
[TBL] [Abstract][Full Text] [Related]
3. The Notch Pathway Promotes Osteosarcoma Progression through Activation of Ephrin Reverse Signaling.
Yu L; Xia K; Gao T; Chen J; Zhang Z; Sun X; Simões BM; Eyre R; Fan Z; Guo W; Clarke RB
Mol Cancer Res; 2019 Dec; 17(12):2383-2394. PubMed ID: 31570655
[TBL] [Abstract][Full Text] [Related]
4. Notch signaling regulates osteosarcoma proliferation and migration through Erk phosphorylation.
Qin J; Wang R; Zhao C; Wen J; Dong H; Wang S; Li Y; Zhao Y; Li J; Yang Y; He X; Wang D
Tissue Cell; 2019 Aug; 59():51-61. PubMed ID: 31383289
[TBL] [Abstract][Full Text] [Related]
5. Cinobufagin induces apoptosis of osteosarcoma cells through inactivation of Notch signaling.
Cao Y; Yu L; Dai G; Zhang S; Zhang Z; Gao T; Guo W
Eur J Pharmacol; 2017 Jan; 794():77-84. PubMed ID: 27845066
[TBL] [Abstract][Full Text] [Related]
6. How the NOTCH pathway contributes to the ability of osteosarcoma cells to metastasize.
Hughes DP
Cancer Treat Res; 2009; 152():479-96. PubMed ID: 20213410
[TBL] [Abstract][Full Text] [Related]
7. Polydatin inhibits proliferation and promotes apoptosis of doxorubicin-resistant osteosarcoma through LncRNA TUG1 mediated suppression of Akt signaling.
Hu T; Fei Z; Su H; Xie R; Chen L
Toxicol Appl Pharmacol; 2019 May; 371():55-62. PubMed ID: 30974157
[TBL] [Abstract][Full Text] [Related]
8. Notch signaling pathway mediates Doxorubicin-driven apoptosis in cancers.
Huang Z; Lin S; Long C; Zhou X; Fan Y; Kuang X; He J; Ning J; Zhang H; Zhang Q; Shen H
Cancer Manag Res; 2018; 10():1439-1448. PubMed ID: 29922088
[TBL] [Abstract][Full Text] [Related]
9. Oleanolic acid induces osteosarcoma cell apoptosis by inhibition of Notch signaling.
Xu Y; Shu B; Tian Y; Wang G; Wang Y; Wang J; Dong Y
Mol Carcinog; 2018 Jul; 57(7):896-902. PubMed ID: 29566282
[TBL] [Abstract][Full Text] [Related]
10. Targeted inhibition of T-cell factor activity promotes syndecan-2 expression and sensitization to doxorubicin in osteosarcoma cells and bone tumors in mice.
Dieudonné FX; Marion A; Marie PJ; Modrowski D
J Bone Miner Res; 2012 Oct; 27(10):2118-29. PubMed ID: 22550000
[TBL] [Abstract][Full Text] [Related]
11. Curcumin inhibits proliferation and invasion of osteosarcoma cells through inactivation of Notch-1 signaling.
Li Y; Zhang J; Ma D; Zhang L; Si M; Yin H; Li J
FEBS J; 2012 Jun; 279(12):2247-59. PubMed ID: 22521131
[TBL] [Abstract][Full Text] [Related]
12. Diallyl trisulfide inhibits proliferation, invasion and angiogenesis of osteosarcoma cells by switching on suppressor microRNAs and inactivating of Notch-1 signaling.
Li Y; Zhang J; Zhang L; Si M; Yin H; Li J
Carcinogenesis; 2013 Jul; 34(7):1601-10. PubMed ID: 23430952
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Notch Signaling During Osteogenic Differentiation in Human Osteosarcoma Cell Line MG63.
Ongaro A; Pellati A; Bagheri L; Rizzo P; Caliceti C; Massari L; De Mattei M
J Cell Physiol; 2016 Dec; 231(12):2652-63. PubMed ID: 26946465
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of BMP9 promotes growth of osteosarcoma mediated by the Notch signaling pathway.
Liu P; Man Y; Wang Y; Bao Y
Oncol Lett; 2016 Feb; 11(2):1367-1370. PubMed ID: 26893744
[TBL] [Abstract][Full Text] [Related]
15. Alopecurone B reverses doxorubicin-resistant human osteosarcoma cell line by inhibiting P-glycoprotein and NF-kappa B signaling.
Xia YZ; Ni K; Guo C; Zhang C; Geng YD; Wang ZD; Yang L; Kong LY
Phytomedicine; 2015 Mar; 22(3):344-51. PubMed ID: 25837271
[TBL] [Abstract][Full Text] [Related]
16. P53 is required for Doxorubicin-induced apoptosis via the TGF-beta signaling pathway in osteosarcoma-derived cells.
Sun Y; Xia P; Zhang H; Liu B; Shi Y
Am J Cancer Res; 2016; 6(1):114-25. PubMed ID: 27073729
[TBL] [Abstract][Full Text] [Related]
17. Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway.
Spina A; Sorvillo L; Di Maiolo F; Esposito A; D'Auria R; Di Gesto D; Chiosi E; Naviglio S
J Cell Physiol; 2013 Jan; 228(1):198-206. PubMed ID: 22674530
[TBL] [Abstract][Full Text] [Related]
18. P65-mediated miR-590 inhibition modulates the chemoresistance of osteosarcoma to doxorubicin through targeting wild-type p53-induced phosphatase 1.
Long X; Lin XJ
J Cell Biochem; 2019 Apr; 120(4):5652-5665. PubMed ID: 30387173
[TBL] [Abstract][Full Text] [Related]
19. A novel derivative of doxorubicin, AD198, inhibits canine transitional cell carcinoma and osteosarcoma cells in vitro.
Rathore K; Cekanova M
Drug Des Devel Ther; 2015; 9():5323-35. PubMed ID: 26451087
[TBL] [Abstract][Full Text] [Related]
20. Autophagy prevents doxorubicin‑induced apoptosis in osteosarcoma.
Zhao D; Yuan H; Yi F; Meng C; Zhu Q
Mol Med Rep; 2014 May; 9(5):1975-81. PubMed ID: 24639013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
